Overview

Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This is a study in Japanese healthy volunteers to determine the safety and tolerability of the compound, AZD5069. It will also assess how the body handles the drug and how it responds to the drug following single and multiple doses up to 11 days.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca